The investigation follows a June 8, 2026, report by short seller Hunterbrook, which claimed that The Ensign Group’s business model relied on inadequate patient care to inflate executive payouts. According to the report, which cited a five-month investigation, these practices allegedly led to patient suffering and fatalities. Following the release of these findings, Ensign Group shares dropped 8.15%.
Rosen Law Firm Probes Securities Claims Against The Ensign Group
The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following allegations that the nursing home operator provided misleading business information. The probe centers on accusations that company profits were driven by understaffing and the manipulation of patient care quality metrics.
Investors who purchased Ensign securities are being invited to participate in a prospective class action. Rosen Law Firm, which operates on a contingency fee basis, is currently seeking lead plaintiffs to recover losses. Shareholders interested in the litigation can contact Phillip Kim at 866-767-3653 or visit the firm's website to submit their information. The firm emphasizes its history in securities litigation, noting past recoveries for investors and various industry rankings, though it reminds potential clients that prior legal outcomes do not guarantee similar results in future cases.
Comments (0)
No comments yet. Be the first!